Literature DB >> 11370855

Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin.

R Shimanovich1, J T Groves.   

Abstract

Peroxynitrite is a known cytotoxic agent that plays a role in many pathological conditions. Various peroxynitrite decomposition catalysts and pathways are being explored to develop efficient therapeutic agents that can safely remove peroxynitrite from cells and tissues. Water-soluble porphyrins, such as iron(III) meso-tetra(2,4,6-trimethyl-3,5-disulfonato)porphine chloride (FeTMPS) and iron(III) meso-tetra(N-methyl4-pyridyl)porphine chloride (FeTMPyP), have been shown to react catalytically with peroxynitrite (ONOO-). However, their mechanisms are yet to be fully understood. In this study, we have explored the reactivity of FeTMPS in the catalytic decomposition of peroxynitrite. The mechanism of this complex process has been determined. According to this mechanism, Fe(III)TMPS is oxidized by peroxynitrite to produce oxoFe(lV)TMPS and NO2 (k1 = 1.3 x 10(5) M(-1)(s(-1). The porphyrin is then reduced back to Fe(III)TMPS by nitrite, but this rate (k2 = 1.4 x 10(4) M(-1)s(-1)) is not sufficient to maintain the catalytic process at the observed rate. The overall rate of peroxynitrite decomposition catalysis, kcat, was determined to be 6 x 10(4) M(-1)s(-1), under typical conditions. We have postulated that an additional reduction pathway must exist. Kinetic simulations showed that a reaction of oxoFe(IV)TMPS with NO2 (k3 = 1.7 x 10(7) M((-1)s(-1)) could explain the behavior of this system and account for the fast reduction of oxoFe(IV)TMPS to Fe(III). Using the kinetic simulation analysis, we have also shown that two other rearrangement reactions, involving FeTMPS and peroxynitrite, are plausible pathways for peroxynitrite decay. A "cage-return" reaction between the generated oxoFe(IV)TMPS and NO2 (k8 = 5.4 x 10(4) M(-1)s(-1)), affording Fe(III)TMPS and nitrate, and a reaction between oxoFe(IV)TMPS and peroxynitrite (k7 = 2.4 x 10(4) M(-1)s(-1)) that affords oxoFe(IV)TMPS and nitrate are presented. The mechanism of FeTMPS-catalyzed peroxynitrite decay differs markedly from that of FeTMPyP, providing some insight into the reactivity of metal centers with peroxynitrite and biologically important radicals such as NO2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11370855     DOI: 10.1006/abbi.2000.2247

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  24 in total

1.  Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Sergey Lupachyk; Alexander Obrosov; John T Groves; Irina G Obrosova; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

Review 2.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

3.  A peroxynitrite complex of copper: formation from a copper-nitrosyl complex, transformation to nitrite and exogenous phenol oxidative coupling or nitration.

Authors:  Ga Young Park; Subramanian Deepalatha; Simona C Puiu; Dong-Heon Lee; Biplab Mondal; Amy A Narducci Sarjeant; Diego del Rio; Monita Y M Pau; Edward I Solomon; Kenneth D Karlin
Journal:  J Biol Inorg Chem       Date:  2009-08-07       Impact factor: 3.358

Review 4.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

5.  Peroxynitrite scavenging by Campylobacter jejuni truncated hemoglobin P.

Authors:  Paolo Ascenzi; Alessandra Pesce
Journal:  J Biol Inorg Chem       Date:  2017-09-02       Impact factor: 3.358

6.  Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.

Authors:  Viktor R Drel; Pal Pacher; Igor Vareniuk; Ivan A Pavlov; Olga Ilnytska; Valeriy V Lyzogubov; Seth R Bell; John T Groves; Irina G Obrosova
Journal:  Int J Mol Med       Date:  2007-12       Impact factor: 4.101

7.  Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity.

Authors:  Dorothée Lahaye; Kannan Muthukumaran; Chen-Hsiung Hung; Dorota Gryko; Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle; Jonathan S Lindsey
Journal:  Bioorg Med Chem       Date:  2007-08-19       Impact factor: 3.641

8.  Direct detection of the oxygen rebound intermediates, ferryl Mb and NO2, in the reaction of metmyoglobin with peroxynitrite.

Authors:  Jia Su; John T Groves
Journal:  J Am Chem Soc       Date:  2009-09-16       Impact factor: 15.419

Review 9.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

Review 10.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.